Canada
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 947.00 M
|
Dec. 31, 2023 | USD 7.37 | 1.49% |
|
Canada |
|
2 |
USD 941.00 M
|
Dec. 31, 2023 | USD 51.80 | -1.93% |
|
Canada |
|
3 |
USD 861.53 M
|
Dec. 31, 2023 | USD 2.05 | 10.27% |
|
Canada |
|
4 |
USD 260.52 M
|
May 31, 2024 | USD 1.08 | 6.36% |
|
Canada |
|
5 |
USD 152.13 M
|
Dec. 31, 2023 | USD 1.74 | -3.87% |
|
Canada |
|
6 |
USD 151.94 M
|
March 31, 2024 | USD 2.55 | 24.33% |
|
Canada |
|
7 |
USD 116.51 M
|
Dec. 31, 2023 | USD 4.00 | 3.39% |
|
Canada |
|
8 |
USD 86.72 M
|
March 31, 2024 | USD 5.35 | 45.09% |
|
Canada |
|
9 |
USD 79.88 M
|
Sept. 30, 2024 | USD 1.61 | 7.63% |
|
Canada |
|
10 |
USD 39.83 M
|
Dec. 31, 2023 | USD 9.51 | -0.80% |
|
Canada |
|
11 |
USD 34.42 M
|
Oct. 31, 2024 | USD 2.82 | 1.40% |
|
Canada |
|
12 |
USD 20.85 M
|
Jan. 31, 2024 | USD 1.68 | 0.14% |
|
Canada |
|
13 |
USD 15.55 M
|
Dec. 31, 2023 | USD 3.27 | 0.93% |
|
Canada |
|
14 |
USD 14.97 M
|
Dec. 31, 2023 | USD 130.84 | 4.17% |
|
Canada |
|
15 |
USD 8.37 M
|
Dec. 31, 2023 | USD 2.38 | -0.15% |
|
Canada |
|
16 |
USD 4.91 M
|
Aug. 31, 2024 | NA |
|
Canada |
The Tobacco company in Canada with the highest Cash and Short-Term Investments is Bausch Health Companies Inc. (Toronto Stock Exchange: BHC.TO) at USD 947.00 M.
The Tobacco company in Canada with the lowest Cash and Short-Term Investments is Cannara Biotech Inc. (TSXV: LOVE.V) at USD 4.91 M.
The top 10 Tobacco companies in Canada by Cash and Short-Term Investments are Bausch Health Companies Inc., Nutrien Ltd., Cronos Group Inc., Tilray Brands, Inc., SNDL Inc., Canopy Growth Corporation, Knight Therapeutics Inc., Aurora Cannabis Inc., OrganiGram Holdings Inc. and Cipher Pharmaceuticals Inc..
The bottom 10 Tobacco companies in Canada by Cash and Short-Term Investments are Cannara Biotech Inc., Swiss Water Decaffeinated Coffee Inc., Lassonde Industries Inc., Achieve Life Sciences, Inc., Roots Corporation, High Tide Inc., Cipher Pharmaceuticals Inc., OrganiGram Holdings Inc., Aurora Cannabis Inc. and Knight Therapeutics Inc..